The KaloBios ticker is KBIO and it is traded on NASDAQ.
January 30, 2013.
260 East Grand Avenue
South San Francisco, CA 94080
31 December
Ernst & Young
KaloBios does not currently have a direct stock purchase plan.
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov.
You can contact KaloBios Investor Relations via our Contact Us web form.
show all
hide all